Cargando…

Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles

BACKGROUND: Cell therapy is a promising strategy for tissue regeneration. Key to this strategy is mobilization and recruitment of exogenous or autologous stem/progenitor cells by cytokines. However, there is no effective cytokine delivery system available for clinic application, in particular for my...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Tan, Ling, Deng, Dengpu, Lu, Ting, Zhou, Changwei, Li, Zhongkui, Tang, Zhenjie, Wu, Zhongshi, Tang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431508/
https://www.ncbi.nlm.nih.gov/pubmed/26056441
http://dx.doi.org/10.2147/IJN.S82091
_version_ 1782371366249431040
author Wang, Bin
Tan, Ling
Deng, Dengpu
Lu, Ting
Zhou, Changwei
Li, Zhongkui
Tang, Zhenjie
Wu, Zhongshi
Tang, Hao
author_facet Wang, Bin
Tan, Ling
Deng, Dengpu
Lu, Ting
Zhou, Changwei
Li, Zhongkui
Tang, Zhenjie
Wu, Zhongshi
Tang, Hao
author_sort Wang, Bin
collection PubMed
description BACKGROUND: Cell therapy is a promising strategy for tissue regeneration. Key to this strategy is mobilization and recruitment of exogenous or autologous stem/progenitor cells by cytokines. However, there is no effective cytokine delivery system available for clinic application, in particular for myocardial regeneration. The aim of this study was to develop a novel cytokine delivery system that is stable in solution at physiological pH. METHODS: Four groups of self-assembled chitosan oligosaccharide/heparin (CSO/H) nanoparticles were prepared with various volume ratios of chitosan oligosaccharide to heparin (5:2, 5:4, 4:15, 1:5) and characterized by laser diffraction, particle size analysis, and transmission electron microscopy. The encapsulation efficiency and loading content of two cytokines, ie, stromal cell-derived factor (SDF)-1α and vascular endothelial growth factor (VEGF) were quantified using an enzyme-linked immunosorbent assay. The biological activity of the loaded SDF-1α and VEGF was evaluated using the transwell migration assay and MTT assay. The dispersion profiles for the cytokine-loaded nanoparticles were quantified using fluorescence molecular tomography. RESULTS: CSO/H nanoparticles were prepared successfully in solution with physiological pH. The particle sizes in the four treatment groups were in the range of 96.2–210.5 nm and the zeta potential ranged from −29.4 mV to 24.2 mV. The loading efficiency in the CSO/H nanoparticle groups with the first three ratios was more than 90%. SDF-1α loaded into CSO/H nanoparticles retained its migration activity and VEGF loaded into CSO/H nanoparticles continued to show proliferation activity. The in vivo dispersion test showed that the CSO/H nanoparticles enabled to VEGF to accumulate locally for a longer period of time. CONCLUSION: CSO/H nanoparticles have a high cytokine loading capacity and allow cytokines to maintain their bioactivity for longer, are stable in an environment with physiological pH, and may be a promising cytokine delivery system for tissue regeneration.
format Online
Article
Text
id pubmed-4431508
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44315082015-06-08 Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles Wang, Bin Tan, Ling Deng, Dengpu Lu, Ting Zhou, Changwei Li, Zhongkui Tang, Zhenjie Wu, Zhongshi Tang, Hao Int J Nanomedicine Methodology BACKGROUND: Cell therapy is a promising strategy for tissue regeneration. Key to this strategy is mobilization and recruitment of exogenous or autologous stem/progenitor cells by cytokines. However, there is no effective cytokine delivery system available for clinic application, in particular for myocardial regeneration. The aim of this study was to develop a novel cytokine delivery system that is stable in solution at physiological pH. METHODS: Four groups of self-assembled chitosan oligosaccharide/heparin (CSO/H) nanoparticles were prepared with various volume ratios of chitosan oligosaccharide to heparin (5:2, 5:4, 4:15, 1:5) and characterized by laser diffraction, particle size analysis, and transmission electron microscopy. The encapsulation efficiency and loading content of two cytokines, ie, stromal cell-derived factor (SDF)-1α and vascular endothelial growth factor (VEGF) were quantified using an enzyme-linked immunosorbent assay. The biological activity of the loaded SDF-1α and VEGF was evaluated using the transwell migration assay and MTT assay. The dispersion profiles for the cytokine-loaded nanoparticles were quantified using fluorescence molecular tomography. RESULTS: CSO/H nanoparticles were prepared successfully in solution with physiological pH. The particle sizes in the four treatment groups were in the range of 96.2–210.5 nm and the zeta potential ranged from −29.4 mV to 24.2 mV. The loading efficiency in the CSO/H nanoparticle groups with the first three ratios was more than 90%. SDF-1α loaded into CSO/H nanoparticles retained its migration activity and VEGF loaded into CSO/H nanoparticles continued to show proliferation activity. The in vivo dispersion test showed that the CSO/H nanoparticles enabled to VEGF to accumulate locally for a longer period of time. CONCLUSION: CSO/H nanoparticles have a high cytokine loading capacity and allow cytokines to maintain their bioactivity for longer, are stable in an environment with physiological pH, and may be a promising cytokine delivery system for tissue regeneration. Dove Medical Press 2015-05-08 /pmc/articles/PMC4431508/ /pubmed/26056441 http://dx.doi.org/10.2147/IJN.S82091 Text en © 2015 Wang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Methodology
Wang, Bin
Tan, Ling
Deng, Dengpu
Lu, Ting
Zhou, Changwei
Li, Zhongkui
Tang, Zhenjie
Wu, Zhongshi
Tang, Hao
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title_full Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title_fullStr Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title_full_unstemmed Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title_short Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
title_sort novel stable cytokine delivery system in physiological ph solution: chitosan oligosaccharide/heparin nanoparticles
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431508/
https://www.ncbi.nlm.nih.gov/pubmed/26056441
http://dx.doi.org/10.2147/IJN.S82091
work_keys_str_mv AT wangbin novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT tanling novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT dengdengpu novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT luting novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT zhouchangwei novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT lizhongkui novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT tangzhenjie novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT wuzhongshi novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles
AT tanghao novelstablecytokinedeliverysysteminphysiologicalphsolutionchitosanoligosaccharideheparinnanoparticles